Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis

The review is withdrawn as it was outdated. A new team of authors, Goossens N, Isgro G, and Negro F, overtook the review title, and a new, revised protocol is published in this April issue of The Cochrane Library 2013. The editorial group responsible for this previously published document have withdrawn it from publication.